{
    "Nature": "48.5",
    "Science": "44.7",
    "Cell": "42.5",
    "Nature Communications": "14.7",
    "Science Advances": "11.7",
    "PNAS": "9.6",
    "Proceedings of the National Academy of Sciences": "9.6",
    "New England Journal of Medicine": "78.5",
    "The Lancet": "88.5",
    "JAMA": "63.1",
    "BMJ": "93.6",
    "Nature Medicine": "58.7",
    "Nature Biomedical Engineering": "26.8",
    "Nature Biotechnology": "33.1",
    "Cell Research": "25.9",
    "Molecular Cancer": "29.9",
    "Signal Transduction and Targeted Therapy": "40.8",
    "Cell Host & Microbe": "18.7",
    "Nature Microbiology": "19.4",
    "mBio": "6.4",
    "mSystems": "5.0",
    "Microbiome": "13.8",
    "The Lancet Microbe": "20.4",
    "PLoS Pathogens": "5.5",
    "Journal of Virology": "3.8",
    "Virology": "2.4",
    "Journal of General Virology": "4.3",
    "Emerging Microbes & Infections": "7.5",
    "Eurosurveillance": "9.9",
    "Antiviral Research": "4.0",
    "Reviews in Medical Virology": "6.6",
    "Current Opinion in Virology": "5.1",
    "Journal of Medical Virology": "4.6",
    "Viruses": "3.5",
    "Retrovirology": "3.9",
    "Virologica Sinica": "4.0",
    "Virus Evolution": "4.0",
    "Journal of Infection": "16.1",
    "Clinical Infectious Diseases": "11.8",
    "The Lancet Infectious Diseases": "36.4",
    "Journal of Infectious Diseases": "5.0",
    "Frontiers in Microbiology": "4.0",
    "Frontiers in Virology": "2.0",
    "Archives of Virology": "2.5",
    "Virus Research": "2.7",
    "NPJ Vaccines": "6.5",
    "Vaccine": "4.5",
    "Vaccines": "5.2",
    "Expert Review of Vaccines": "4.8",
    "Human Vaccines & Immunotherapeutics": "3.5",
    "Clinical and Vaccine Immunology": "3.2",
    "Frontiers in Immunology": "5.7",
    "Science Immunology": "24.8",
    "Nature Immunology": "27.7",
    "Immunity": "32.4",
    "Cell Reports Medicine": "14.3",
    "Molecular Therapy": "12.0",
    "Molecular Therapy - Nucleic Acids": "7.0",
    "Molecular Therapy - Methods & Clinical Development": "4.6",
    "Molecular Therapy - Oncolytics": "4.1",
    "Gene Therapy": "4.5",
    "Human Gene Therapy": "4.2",
    "Journal of Controlled Release": "10.5",
    "Biomaterials": "12.8",
    "Small": "13.0",
    "ACS Nano": "15.8",
    "Nano Letters": "9.6",
    "Advanced Materials": "26.8",
    "Bioactive Materials": "18.0",
    "Journal of Extracellular Vesicles": "15.5",
    "Nucleic Acids Research": "16.6",
    "Nature Reviews Drug Discovery": "101.8",
    "CA: A Cancer Journal for Clinicians": "254.7",
    "Nature Cancer": "23.5",
    "Cancer Cell": "48.8",
    "Cancer Discovery": "29.7",
    "Lancet Oncology": "35.9",
    "JAMA Oncology": "28.4",
    "Journal of Clinical Oncology": "42.1",
    "Annals of Oncology": "65.4",
    "Molecular Cancer": "29.9",
    "Journal of Hematology & Oncology": "23.6",
    "Molecular Cancer": "27.7",
    "Clinical Cancer Research": "10.0",
    "Cancer Research": "11.2",
    "Oncogene": "6.9",
    "Cancer Communications": "16.2",
    "Journal of Thoracic Oncology": "20.4",
    "Journal of ImmunoTherapy of Cancer": "10.9",
    "Leukemia": "11.4",
    "Blood": "20.3",
    "Blood Cancer Journal": "11.8",
    "Haematologica": "9.0",
    "Seminars in Cancer Biology": "12.3",
    "Cancer Letters": "9.1",
    "International Journal of Cancer": "5.7",
    "British Journal of Cancer": "8.0",
    "European Journal of Cancer": "8.4",
    "Theranostics": "12.4",
    "Journal of Experimental & Clinical Cancer Research": "11.3",
    "Cancer Immunology Research": "8.1",
    "Molecular Oncology": "6.6",
    "OncoImmunology": "7.2",
    "Stem Cell Reports": "5.9",
    "Cell Stem Cell": "19.8"
}
